Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia
ABSTRACT: Objectives: Colistin, an important drug to treat carbapenem-resistant Acinetobacter baumannii (CRAB) infections, has a narrow therapeutic window with nephrotoxicity. This study was conducted to determine the importance of colistin concentrations in predicting nephrotoxicity when treating...
Guardado en:
Autores principales: | Yun-Jeong Jeong, Namyi Gu, Won Gun Kwack, Yunseong Kang, Seong Yeon Park, Young-Soon Yoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8043ad844d341209a45ec772b28ae36 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
¿Se debe revisar la determinación de la CIM de colistín en Acinetobacter baumannii?
por: Villanueva,Xabier, et al.
Publicado: (2017) -
New Mutations Involved in Colistin Resistance in <named-content content-type="genus-species">Acinetobacter baumannii</named-content>
por: Bingbing Sun, et al.
Publicado: (2020) -
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant <named-content content-type="genus-species">Acinetobacter baumannii</named-content> Clinical Isolates
por: Vincent Trebosc, et al.
Publicado: (2019) -
Colistin Resistance Onset Strategies and Genomic Mosaicism in Clinical <i>Acinetobacter baumannii</i> Lineages
por: Viviana Cafiso, et al.
Publicado: (2021) -
Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015–2019)
por: Patrick Chhatwal, et al.
Publicado: (2021)